Telix Pharmaceuticals Limited Stock
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
09:13:48 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 15.67 AUD | -6.50% |
|
-4.86% | +39.91% |
| 09-11 | ASX Biggest Losers | MT |
| 09-03 | ASX Biggest Gainers | MT |
| Market Cap | 5.32B 3.82B 3.29B 3.12B 2.82B 5.3B 365B 37B 14.23B 186B 14.34B 14.03B 586B | P/E 2026 * |
230x | P/E 2027 * | 205x |
|---|---|---|---|---|---|
| Enterprise Value | 5.75B 4.13B 3.55B 3.37B 3.05B 5.72B 394B 39.97B 15.37B 200B 15.49B 15.15B 634B | EV / Sales 2026 * |
4.21x | EV / Sales 2027 * | 3.7x |
| Free-Float |
83.1% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| TLX | Delayed | |
Tradegate
| T3X | Real-time | |
OTC Markets
| TLPP.F | Delayed | |
Boerse Muenchen
| T3X | Real-time | |
Börse Stuttgart
| T3X | Delayed | |
Deutsche Boerse AG
| T3X | Delayed |
Last Transcript : Telix Pharmaceuticals Limited
| 1 day | -6.50% | ||
| 1 week | -4.86% | ||
| Current month | +2.02% | ||
| 1 month | -7.55% | ||
| 3 months | +16.33% | ||
| 6 months | +45.63% | ||
| Current year | +39.91% |
| 1 week | 15.5 | 17 | |
| 1 month | 14.86 | 18.13 | |
| Current year | 8.26 | 18.13 | |
| 1 year | 8.26 | 18.32 | |
| 3 years | 8.2 | 31.97 | |
| 5 years | 3.55 | 31.97 | |
| 10 years | 0.46 | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 03/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 61 | 31/07/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 03/01/2017 | |
Mark Nelson
CHM | Chairman | 66 | 03/02/2026 |
Jann Skinner
BRD | Director/Board Member | 68 | 19/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/26/26 A | Free | Director | 21,597 | 0.0064% | ||
| 5/26/26 A | Free | Founder | 339,845 | 0.1001% | ||
| 5/26/26 A | Free | Director | 21,597 | 0.0064% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.50% | -4.86% | +13.72% | +38.55% | 4.08B | ||
| -0.71% | -6.35% | -4.87% | +9.03% | 46.05B | ||
| +0.21% | -2.98% | +340.68% | +519.93% | 43.59B | ||
| +1.74% | -2.24% | +37.28% | +21.57% | 42.35B | ||
| +1.38% | -3.28% | +3.23% | +65.60% | 38.86B | ||
| -1.44% | -5.26% | +8.78% | +36.85% | 32.24B | ||
| +0.87% | -2.60% | - | - | 17.16B | ||
| +0.75% | -0.64% | +18.07% | +110.32% | 16.28B | ||
| -0.31% | -2.78% | +10.47% | +30.49% | 14.32B | ||
| +1.93% | -3.55% | +74.20% | +39.37% | 13.03B | ||
| Average | -0.21% | -3.50% | +55.73% | +96.86% | 26.8B | |
| Weighted average by Cap. | +0.29% | -4.39% | +72.08% | +122.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.37B 979M 844M 799M 724M 1.36B 93.56B 9.49B 3.65B 47.6B 3.68B 3.6B 150B | 1.57B 1.13B 973M 921M 835M 1.57B 108B 10.94B 4.21B 54.88B 4.24B 4.15B 173B |
| Net income | 24.95M 17.9M 15.42M 14.6M 13.23M 24.83M 1.71B 173M 66.69M 870M 67.22M 65.74M 2.75B | 13.79M 9.89M 8.52M 8.07M 7.32M 13.72M 945M 95.85M 36.86M 481M 37.15M 36.34M 1.52B |
| Net Debt | 427M 306M 264M 250M 227M 425M 29.27B 2.97B 1.14B 14.89B 1.15B 1.13B 47.05B | 495M 355M 306M 289M 262M 492M 33.88B 3.44B 1.32B 17.24B 1.33B 1.3B 54.47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | A$15.67 | -6.50% | 2,193,327 |
| 10/09/26 | A$16.76 | +0.42% | 1,759,963 |
| 09/09/26 | A$16.69 | +1.15% | 1,109,874 |
| 08/09/26 | A$16.50 | +1.54% | 1,119,678 |
| 07/09/26 | A$16.25 | -1.34% | 1,122,950 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions

















